Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Greenwave Technology Solutions, Inc. - Common Stock (NQ:GWAV)

0.2083 -0.0037 (-1.75%)
Streaming Delayed Price Updated: 9:55 AM EDT, May 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Greenwave Technology Solutions, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
12 Industrials Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
12 Industrials Stocks Moving In Friday's Intraday Session
  
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 39 companies reached new 52-week lows. 
Via Benzinga
12 Industrials Stocks Moving In Thursday's Pre-Market Session
  
Via Benzinga
Why Is Disney Higher By More Than 7%: Here Are 40 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning! We're starting off Thursday with an overview of the biggest pre-market stock movers that traders need to watch! 
Via InvestorPlace
12 Industrials Stocks Moving In Wednesday's After-Market Session
  
Via Benzinga
12 Industrials Stocks Moving In Friday's Pre-Market Session
  
Via Benzinga
11 Industrials Stocks Moving In Thursday's Pre-Market Session
  
Via Benzinga
12 Industrials Stocks Moving In Tuesday's After-Market Session
Gainers Highway Holdings (NASDAQ:HIHO) shares increased by 11.3% to $2.06 during Tuesday's after-market session. 
Via Benzinga
Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday. 
Via Benzinga
Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday's Mid-Day Session
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.